Podcasts about advancing innovation

This conversation took place during our March 24 event, “Advancing Innovation and Fairness in Small Business Finance,” hosted by the Responsible Business Lending Coalition and the Aspen Institute's Business Ownership Initiative. It features opening remarks from Joyce Klein (The Aspen Institute) and Louis Caditz-Peck (Responsible Business Lending Coalition), followed by a conversation with Michael Barr (Federal Reserve Board of Governors), moderated by Klein.Ten years ago, when the Responsible Business Lending Coalition was founded, the nation was experiencing dramatic changes in the small business financing landscape, stemming in part from market adjustments after the Great Recession. Ten years later, the forces driving change are accelerating. The growth in new technologies, including AI; the aftermath of the COVID pandemic; and unprecedented growth in new small businesses starting are only some of the factors shaping the market.Yet the challenge remains: how do we harness the power of technology and innovation to drive greater prosperity and inclusion for small business owners, while ensuring that financial products support small businesses rather than undermine them?During this event, we heard perspectives from lenders, investors, policymakers, small business owners, and advocates about how to build a financing market that truly works for small businesses. The event featured three moderated conversations highlighting key trends, opportunities, and challenges in the small business financing market, followed by a reception that gave attendees the opportunity to explore this issue in greater detail with fellow stakeholders.For more information, including a transcript, speaker bios, and additional resources, visit: https://www.aspeninstitute.org/events/advancing-innovation-and-fairness-in-small-business-finance/Or subscribe to our podcast to listen on the go: https://podcasters.spotify.com/pod/show/aspeneopFor more information about the Responsible Business Lending Coalition, visit: https://www.borrowersbillofrights.org/We thank our colleagues at Community Investment Management for their generous support of this event.

This conversation took place during our March 24 event, “Advancing Innovation and Fairness in Small Business Finance,” hosted by the Responsible Business Lending Coalition and the Aspen Institute's Business Ownership Initiative. It features a panel discussion with Mickey Konson (Quantum Financial), Phil Goldfeder (American Fintech Council), Luz Urrutia (Accion Opportunity Fund), and moderator Jacob Haar (Community Investment Management).Ten years ago, when the Responsible Business Lending Coalition was founded, the nation was experiencing dramatic changes in the small business financing landscape, stemming in part from market adjustments after the Great Recession. Ten years later, the forces driving change are accelerating. The growth in new technologies, including AI; the aftermath of the COVID pandemic; and unprecedented growth in new small businesses starting are only some of the factors shaping the market.Yet the challenge remains: how do we harness the power of technology and innovation to drive greater prosperity and inclusion for small business owners, while ensuring that financial products support small businesses rather than undermine them?During this event, we heard perspectives from lenders, investors, policymakers, small business owners, and advocates about how to build a financing market that truly works for small businesses. The event featured three moderated conversations highlighting key trends, opportunities, and challenges in the small business financing market, followed by a reception that gave attendees the opportunity to explore this issue in greater detail with fellow stakeholders.For more information, including a transcript, speaker bios, and additional resources, visit: https://www.aspeninstitute.org/events/advancing-innovation-and-fairness-in-small-business-finance/Or subscribe to our podcast to listen on the go: https://podcasters.spotify.com/pod/show/aspeneopFor more information about the Responsible Business Lending Coalition, visit: https://www.borrowersbillofrights.org/We thank our colleagues at Community Investment Management for their generous support of this event.

This conversation took place during our March 24 event, “Advancing Innovation and Fairness in Small Business Finance,” hosted by the Responsible Business Lending Coalition and the Aspen Institute's Business Ownership Initiative. It features a panel discussion with Cailey Locklair (Maryland Retailers Alliance), Hal Martin (Federal Reserve Bank of Cleveland), Carolina Martinez (CAMEO Network), Awesta Sarkash (Small Business Majority), and moderator Louis Caditz-Peck (Responsible Business Lending Coalition).Ten years ago, when the Responsible Business Lending Coalition was founded, the nation was experiencing dramatic changes in the small business financing landscape, stemming in part from market adjustments after the Great Recession. Ten years later, the forces driving change are accelerating. The growth in new technologies, including AI; the aftermath of the COVID pandemic; and unprecedented growth in new small businesses starting are only some of the factors shaping the market.Yet the challenge remains: how do we harness the power of technology and innovation to drive greater prosperity and inclusion for small business owners, while ensuring that financial products support small businesses rather than undermine them?During this event, we heard perspectives from lenders, investors, policymakers, small business owners, and advocates about how to build a financing market that truly works for small businesses. The event featured three moderated conversations highlighting key trends, opportunities, and challenges in the small business financing market, followed by a reception that gave attendees the opportunity to explore this issue in greater detail with fellow stakeholders.For more information, including a transcript, speaker bios, and additional resources, visit: https://www.aspeninstitute.org/events/advancing-innovation-and-fairness-in-small-business-finance/Or subscribe to our podcast to listen on the go: https://podcasters.spotify.com/pod/show/aspeneopFor more information about the Responsible Business Lending Coalition, visit: https://www.borrowersbillofrights.org/We thank our colleagues at Community Investment Management for their generous support of this event.

African Americans have had long standing impacts in the field of innovation as inventors to entrepreneurs. In this episode, we will talk to serial entrepreneurs Erin Horne McKinney and John Pasmore to share how Black Tech founders are advancing their ideas, while navigating barriers that limit access to capital and relevant networks. Hosted on Acast. See acast.com/privacy for more information.

As the workforce evolves, so does the opportunity to harness the power of a blended approach. In this episode, author and researcher Sara Daw, MBA, joins us to discuss the increasingly relevant topic of the blended workforce. Sara discusses how combining full-time employees with fractional, freelance, or contract team members can drive innovation, increase flexibility, and provide access to specialized expertise when and where it's needed.

Christina Luke Luna, Chief Learning Officer for Digital Promises' Center for Learners Pathways, is joined by Bianca Alvarado, Director of Digital Promises' San Diego STEM Pathways Initiative, to discuss the mission of Digital Promise; the STEM Pathways Initiative; and the San Diego STEM Pathways Community Advisory Committee.https://digitalpromise.org/initiative/strengthening-stem-pathways-in-san-diego/ About Spotlight and Cloudcast Media"Spotlight On The Community" is the longest running community podcast in the country, continuously hosted by Drew Schlosberg for 19 years.  "Spotlight" is part of Cloudcast Media's line-up of powerful local podcasts, telling the stories, highlighting the people, and celebrating the gravitational power of local. For more information on Cloudcast and its shows and cities served, please visit www.cloudcastmedia.us.Cloudcast Media | the national leader in local podcasting.  About Mission Fed Credit UnionA community champion for over 60 years, Mission Fed Credit Union with over $6 billion in member assets, is the Sponsor of Spotlight On The Community, helping to curate connectivity, collaboration, and catalytic conversations.  For more information on the many services for San Diego residents, be sure to visit them at https://www.missionfed.com/

In this episode of the Better Tech podcast, host Jocelyn Houle speaks with Michael Taylor, CTO and EVP of Worldwide Tech, about the intersection of innovation and leadership in technology. They delve into the company's culture of innovation, the role of leadership in fostering creativity, and the importance of learning from mistakes. Mike shares insights on the evolving landscape of AI, emphasizing the need for speed in adopting AI technologies and establishing a center of excellence. The discussion highlights the practical application of innovation strategies in real-world scenarios, particularly in customer service and coding, and the cultural shifts required to embrace AI. Michael also underscores the value of diverse perspectives and community engagement in driving technology initiatives.

Hello and welcome to the ZimmCast. In this episode I am going to share some audio from the recent Syngenta Media Summit 2024 that was held in the new crop protection facility in Greensboro, NC. I am grateful for the opportunity to be with a group of agricultural journalists and have personal time with Syngenta leadership. You'll hear more about the new facility. I have created a virtual newsroom on AgNewsWire that contains photos as well as interviews and other audio for ag media to use. I've picked out the welcome we had from Jeff Cecil, Head of North America Crop Protection Marketing, in the form of a one on one interview about advancing innovation for the US grower. After that you'll hear closing comments from Vern Hawkins, Regional Director, North America President. He focused on advancing American agriculture.  That's the ZimmCast for now. Please let me know if you have ideas for a future podcast. Just email me at chuck@zimmcomm.biz.

Get an exclusive look at the cutting-edge research on ocular melanoma, uveal melanoma, retinoblastoma, and more in this eye-opening video on eye cancer in 2024!Eye on Research 2024: Advancing Innovation in Cancer Research and TreatmentDescription:Welcome to the second annual "Eye on Research 2024" event! We are thrilled to be joined by a panel of esteemed doctors and researchers who are leading groundbreaking efforts in cancer research and treatment. Special thanks to all our guest doctors, including Dr. Correa and others, for their dedication to improving patient outcomes through innovation and cutting-edge science.Dr. Correa: Leading discussions on the latest advancements in cancer immunotherapy and the importance of personalized medicine in treating cancer patients.Additionally, we extend our gratitude to our generous sponsors, including Castle Biosciences, IDEAYA Biosciences, Aura Biosciences, TriSalus Life Sciences, Immunocore, Delcath, and Replimune, for making this event possible.Join us for this exciting session as we explore new frontiers in cancer research, including clinical trials, treatment strategies, and the potential for future breakthroughs. Thank you to everyone for being part of this incredible journey!

Welcome to Neurocareers, the podcast that proves the impossible is possible! We're thrilled to bring you the second episode of our BCI Award Neurocareers series featuring Prof. Nicholas Opie, the mastermind behind the revolutionary Stentrode and endovascular neural interfaces. Prof. Opie, a biomedical engineer and the founding CTO of Synchron, knows what it takes to succeed in the innovative field of neurotech. Prof. Opie's Stentrode project won 1st place in the International BCI Award competition in 2021. In this podcast episode, he'll share his top tips for winning the International BCI Award and building a successful career in the industry. Join us as we dive deep into the Stentrode revolution and discover how endovascular neural interfaces are changing the game. Prof. Opie will take us through his groundbreaking research and share insights on making the impossible possible in neurotech. As always, Neurocareers inspires and educates you on the exciting and ever-evolving world of neuroscience and neurotechnologies. Don't miss this opportunity to learn from one of the best in the field! This BCI Award Neurocareers series is a partnership between Milena Korostenskaja, PhD at the Institute of Neuroapproaches, and Christoph Guger, PhD at g.tec biomedical engineering. About the Podcast Guest: Professor Nicholas Opie, BE BSc PhD MBA, is a leading biomedical engineer and an expert in neural interfaces. He currently serves as the Laboratory Head of the Vascular Bionics Laboratory in the Department of Medicine at the University of Melbourne, where he is also an NHMRC Research Fellow. Throughout his career, Prof Opie has brought multiple biomedical devices from concept to clinic, including a suprachoroidal retinal prosthesis (bionic eye) that aims to restore vision to individuals with profound vision loss, and a motor neuron prosthesis (bionic spine) that seeks to restore independence, communication, and mobility to individuals with paralysis. He has published over 55 peer-reviewed journal articles, including in Nature Biomedical Engineering and Nature Biotechnology. Additionally, he has filed over 90 patents and was awarded the 2021 NFMRI John Raftos AM Award for Advancing Innovation. Prof Opie is also Synchron's founding Chief Technology Officer (CTO), a neural interface company based in Melbourne and New York. He has raised over AUD$210M in private funding and grants and designed Synchron's flagship product, the Stentrode™. The Stentrode is listed in Time Magazine's Top 100 Inventions of 2021 and aims to provide treatment for debilitating medical illnesses while empowering patients by reconnecting them online in ways that dramatically improve their lives. Following a successful first-in-human trial conducted in Australia on the Stentrode motor neuroprosthesis, Prof Opie and Synchron recently received approval from the US FDA. This approval paves the way for a trial in the US, which will commence this year and represents a significant step towards the first FDA approval for implantable brain-computer interfaces. To learn more about Prof Opie and his work, visit his profile page at the University of Melbourne: https://findanexpert.unimelb.edu.au/profile/430403-nicholas-opie. You can also check out the Stentrode SWITCH study, which involved four patients: https://pubmed.ncbi.nlm.nih.gov/36622685/. Learn more about Synchron's innovative technology on their website: https://synchron.com/. Finally, connect with Prof Nicholas Opie on LinkedIn: https://www.linkedin.com/in/professor-nicholas-opie-4603289a/. About the podcast host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news  

Neurotechnology like DBS or transcranial magnetic stimulation have clear benefits in diagnosis and therapy and are largely embraced by the medical community. But what about recent accelerated development from tech entrepreneurs to harness cognitive pathways for everyday tasks? This is referred to as brain computer interface technology or BCI. Commercial products such as Neuralink, attempt to implant chips promising to link brain activity with tasks such as accessing phones or cars. This brings up real questions on autonomy, privacy, and medical implications, but is there more to these technological advancements that could provide medical benefit for our patients? We discuss the commercial and medical aspects surrounding BCI technology and the physician and scientist's role in this rapidly evolving field with Dr. Karen Rommelfanger, the founder and director of the Neuroethics Program at Emory University and now the founder of the world's first think and DO tank dedicated wholly to neuroethics called the Institute of Neuroethics. She also serves as a member of the BRAIN Initiative's Neuroethics Working Group and was on the advisory council to the director of the National Institutes of Health (NIH) for BRAIN 2025. Series 4, Episode 1. Featuring: Guest: Dr. Karen Rommelfanger, Emory University & Institute of Neuroethics Interviewer/Producer: Rohini Samudralwar, University of Pennsylvania

Today's guest hails from a small country in the heart of Europe which most people know little about. Luxembourg's economy was once based on agriculture and coal mining, but central to its success today is its thriving innovation ecosystem that is geared towards the creation and transfer of knowledge. Christophe Haunold is the Head of Partnership, Knowledge, and Technology Transfer at the University of Luxembourg, and the recently appointed President of ASTP. He believes that knowledge transfer is the key to mitigating many of the issues that plague our world. Christophe joins us for a discussion about the work that he is doing to advance innovation, some of the most important lessons he has learned during his career, and a few of the biggest professional challenges that he is currently facing.    In This Episode: [00:52] Introducing today's guest, Head of Partnership, Knowledge, and Technology Transfer at the University of Luxembourg, Christophe Haunold. [01:37] Christophe shares an overview of what his career has looked like to date.  [03:29] A brief history of Luxembourg. [05:02] Pros and cons of the knowledge transfer ecosystem in Luxembourg.  [08:59] The key actions that Christophe and his team focus on.  [11:52] Factors that Christophe sees as essential to the successful management of innovation.  [13:33] The University of Luxembourg's approach to supporting startups and spinouts.  [16:48] Funding opportunities available for startups and spinouts that come out of the University of Luxembourg.  [18:22] Examples of corporate partnerships that the University of Luxembourg has entered into.  [21:22] Valuable lessons that Christophe has learned through failure.   [23:03] One of Christophe's favorite success stories.  [25:13] The biggest challenges that Christophe's office is currently facing.  [27:12] The goals of ASTP and what Christophe hopes to achieve as its new president.  [30:38] Christophe's three big wishes for the knowledge transfer field.    Find Christophe: Email  

In this episode of Who Would Have Thought, we welcome Shane Curd, Head of Healthcare Marketing at Connect America, the leading provider of connected health solutions that are dedicated to improving access to care, safety, and independence. Shane is also the Founder of Fresno Technology Affinity Group, a group that has consulted for dozens of startups on marketing and product strategy to successfully penetrate payer and enterprise health system markets. Tune in to learn about recent advances and innovation in medication adherence, remote patient monitoring (RPM), and artificial intelligence in the sector of healthcare known as “Age Tech”. You'll gain insight into the impacts of RPM innovation on providers, patients' quality of life, and payer acceptance as well as how RPM and AI can help with management of medication adherence. Shane also highlights a few recent AI advancements in Age Tech and what Connect America is focusing on in the coming years.To learn more about Connect America, visit: www.connectamerica.com About Our Guest:Shane Curd is the Head of Healthcare Marketing at Connect America, the leading provider of connected health solutions that are dedicated to improving access to care, safety, and independence. Shane is also the Founder of Fresno Technology Affinity Group which has consulted for dozens of startups on marketing and product strategy to successfully penetrate payer and enterprise health system markets. Shane leverages his unique combination of marketing experience, technical expertise, and interpersonal skills to drive sales and market expansion within the healthcare space. He has built, launched, marketed and led commercialization efforts for over a dozen products in the healthcare space including remote patient monitoring (RPM), medical devices, outcomes analytics, and revenue cycle management.Connect with Shane on LinkedIn: www.linkedin.com/in/shanecurd/About SmartTab: SmartTab is driving the future of digital medicine by developing a superior patient-centered personalized drug delivery platform in the form of a wireless ingestible capsule. The patient experience fuels SmartTab's commitment to create novel, effective therapies that improve patient outcomes and compliance. For more information visit: www.smarttab.coQuotes: “Today, Connect America monitors nearly a million people and then they support about 35,000 through remote patient monitoring. Then, about 250,000 senior living residents across North America…The fact that they're embracing innovation and we're talking beyond “pushing the button” and getting help is very exciting.”“We studied the effectiveness of RPM around obesity, diabetes, and hypertension and we saw improvements across all categories. So, the fact that it's effective and helping people in connecting them with their provider, we're getting rave reviews all around.”“Many people are aging with chronic conditions and if they're managed appropriately, they have minimal impact on their life. So, I think the real challenge is to continue to enable seniors to age gracefully at home.”

What if your computer could receive directions directly from your thoughts? No keyboard or mouse required? That is exactly what we talk about in this week's Fish Fry podcast! Evan Coopersmith (EVP of Data Science at AE Studio) joins me to discuss the newest advancements in brain computer interface technology. Evan and I chat about the details of the recent Neural Latents Benchmark Challenge, how AE Studio is leveraging their expertise in machine learning to encourage innovation in BCI technology, and why neuroethical principles that increase human agency are vital to the future of brain computer interface technology.  

Today, Dr. Neera Nathan and our returning guest, Dan Hodgdon emphasize the impact of the integrated hair wellness approach and how to stimulate dormant hair follicles and restore growth naturally. Stay tuned for more practical and easy self-care recommendations that improve whole-body health and wellness!   Key Takeaways From This Episode Why it's important to take an integrative approach to hair wellness? What can we do to regrow hair naturally? What is the ENSO Collection and how is it unique? Clean beauty movement: Definition, purpose, and precautions  What is Prejuvenation and why should you do it? Self-care tips to improve your overall health and wellness   Resources Mentioned In This Episode Dan Hodgdon | Keys to Healthy and Beautiful Hair From the Founder of Vegamour   About Dr. Neera Nathan and Dan Hodgdon Dr. Nathan is a dermatologist and laser researcher at Massachusetts General Hospital in Boston, Massachusetts. While completing her dermatology residency, she had the privilege of training with international leaders in lasers and aesthetic medicine, skin cancer, and medical dermatology. She has authored 25 dermatology publications to date and has presented her work at local, national, and international forums. She has received scholarships and grants from the National Institutes of Health, the Doris Duke Charitable Foundation, Advancing Innovation in Dermatology, the American Society for Laser Medicine and Surgery, and the American Society for Dermatologic Surgery. She is passionate about the science behind skincare, medical education, advocacy, and mentorship.  Dan Hodgdon is an emerging leader in the clean beauty movement, helping to shape the future of a massively influential industry. As CEO of VEGAMOUR - one of the world's fastest-growing hair brands - the Los Angeles-based executive has created a first-of-its-kind line of plant-based hair-wellness products for women, revealing entirely new possibilities at the intersection of sustainability and science. Founded in 2016, VEGAMOUR takes a uniquely holistic and science-driven approach to hair health, formulating all its products with non-toxic, organic, wild-harvested ingredients used in amounts clinically proven to boost hair density and volume. Connect with Dan and Dr. Neera  Website: www.vegamour.com Instagram: @vegamour  Facebook: Vegamour   Use code GREATLY20! and get a 20% off on your first purchase at www.vegamour.com.   Kristel Bauer, the Founder of Live Greatly, is on a mission to help people thrive personally and professionally. She is a corporate wellness expert, Integrative Medicine Fellow, Keynote Speaker, TEDx speaker & Physician Assistant experienced in Integrative Psychiatry and Functional Medicine.    Follow her on: Instagram: @livegreatly_co Clubhouse: @livegreatly LinkedIn: Kristel Bauer Youtube: Live Greatly, Kristel Bauer   To Book Kristel as a speaker for your next event, click here.  

En la edición de hoy de Más Allá de la Innovación y en nuestro apartado de entrevistas tenemos el placer y el honor de contar con Maysoun Douas. Maysoun es Cofundadora de Excellenting, algoritmo para el emparejamiento de oferta y demanda tecnológica mediante el mapeo de innovaciones, y experta en innovación. Es igualmente Concejal del Ayuntamiento de Madrid y Doctora en física por la UAM, tras más de 7 años de investigación. Ha trabajado con entidades de la talla de la Comisión Europea y el Center for Advancing Innovation. Como constructora de comunidades ha alimentado ecosistemas, juntando actores económicos para crear oportunidades de desarrollo e innovación. Tanto en Al Sharq Youth Forum como en La Nave, o recientemente en la Fundación Tamkeen. Con nuestra invitada tendremos la oportunidad de hablar de educación y formación y de cómo innovar en estos temas fundamentales. Igualmente veremos la Innovación en las administraciones públicas, desde una doble vertiente. Por un lado sobre como puede apoyarse desde la administración a los innovadores y emprendedores y, por otro, cómo se puede innovar para mejorar la relación admistración-ciudadanos y ciudadanas. En relación a ello incidiremos especialmente en la IA, el Blockchain y en las conocidas como GovTech. Contacto: https://www.mypublicinbox.com/MasAlladelaInnovacion Música: https://incompetech.filmmusic.io/ by Kevin McLeod Licencia : Creative Commons (CC BY-NC-SA)

En la edición de hoy de Más Allá de la Innovación y en nuestro apartado de entrevistas tenemos el placer y el honor de contar con Maysoun Douas. Maysoun es Cofundadora de Excellenting, algoritmo para el emparejamiento de oferta y demanda tecnológica mediante el mapeo de innovaciones, y experta en innovación. Es igualmente Concejal del Ayuntamiento de Madrid y Doctora en física por la UAM, tras más de 7 años de investigación. Ha trabajado con entidades de la talla de la Comisión Europea y el Center for Advancing Innovation. Como constructora de comunidades ha alimentado ecosistemas, juntando actores económicos para crear oportunidades de desarrollo e innovación. Tanto en Al Sharq Youth Forum como en La Nave, o recientemente en la Fundación Tamkeen. Con nuestra invitada tendremos la oportunidad de hablar de educación y formación y de cómo innovar en estos temas fundamentales. Igualmente veremos la Innovación en las administraciones públicas, desde una doble vertiente. Por un lado sobre como puede apoyarse desde la administración a los innovadores y emprendedores y, por otro, cómo se puede innovar para mejorar la relación admistración-ciudadanos y ciudadanas. En relación a ello incidiremos especialmente en la IA, el Blockchain y en las conocidas como GovTech. Contacto: https://www.mypublicinbox.com/MasAlladelaInnovacion Música: https://incompetech.filmmusic.io/ by Kevin McLeod Licencia : Creative Commons (CC BY-NC-SA)

The AIRE program is a new approach to offering fellowships in sleep medicine using a competency-based curriculum and uniform evaluation tools. In this episode of Talking Sleep, we discuss the AIRE program with several guests, including program directors and fellows. Participants in the AIRE fellowship can complete their sleep training as part of a blended or parttime program, with the goal of increasing the number of sleep specialists.

Dr. David Vance gave this exclusive webinar to our SCALE Challenge participants as a part of The Center for Advancing Innovation's award-winning virtual accelerator program. Dr. Vance is the President at Vance Intellectual Property and has over 20 years of patent experience in various fields, particularly the pharmaceutical and chemical arts. He's drafted and prosecuted numerous high-level patent applications relating to chemical processes, pharmaceuticals, semiconductor processing, organic light-emitting diodes, graphene production, and chemical sensors.

One of the hurdles with innovation is having the idea and getting it off the ground. The SCALE Challenge (Supply Chain And Logistics Enterprises), run by the Centre for Advancing Innovation and Rosemarie Truman will help you shortcut this and could lead to new, astonishing, disruptive businesses. The post 034: SCALE Innovation Challenge with Rosemarie Truman appeared first on OB&Co.

In this special sponsored episode of Curiosity Daily, Cody Gough and Ashley Hamer talk to Brent Lessard, the founder and lead project manager on rFlight, and Thierry Marin-Martinod, VP Engineering & CTO at TE Connectivity and a subject matter expert who is the liaison with rFlight, to help you learn about the engineering partnership advancing innovation in the sky. Learn more about TE Connectivity and rFlight: TE Connectivity — https://curiosity.im/2Ys94RC rFlight — http://www.rflight.org/ The GoFly Competition Will Put Humans in the Sky — https://curiosity.im/2I2fUHE An Award-Winning Hyperloop Company Sets Its Sights on Human Flight — https://curiosity.im/2HQTclT Here's Why So Many Breakthroughs Come Out of Big Competitions — https://curiosity.im/2YA1fcS If you love our show and you're interested in hearing full-length interviews, then please consider supporting us on Patreon. You'll get exclusive episodes and access to our archives as soon as you become a Patron! https://www.patreon.com/curiositydotcom Download the FREE 5-star Curiosity app for Android and iOS at https://curiosity.im/podcast-app. And Amazon smart speaker users: you can listen to our podcast as part of your Amazon Alexa Flash Briefing — just click “enable” here: https://curiosity.im/podcast-flash-briefing.

ForbesBooks.com/SBECouncil

080 | Pursuing cures and advancing innovation   Welcome to another episode of Biotechnology Focus radio! I am your host – Michelle Currie – here to give you the rundown on what’s been happening on Canada’s biotech scene. It has been a busy last couple of weeks as the new genomics cloud platform was launched, a researcher from Roche Canada shares her input on future of innovation in cancer care, and the fight against cancer innovation trust invests almost half a mil in Ontario research technologies.   +++++  The world is opening up to the idea of genome sequencing. What was once a far-fetched idea is now beginning to materialize – and we are only at the tip of the iceberg. Information technology like Facebook, Google, Wikipedia and Uber are all prime examples of impactful software platforms that connect people with data that have set the stage for the next act.  When you look at where DNA sequencing began back in the 1970’s with the “Sanger sequencing method” as a process of determining the order of bases in the length of DNA, we’ve come a long way. But still, researchers are at the forefront of this revolution of gathering our personalized genetic information and using it to power the next generation of safer and more effective “precision” medicines.  This is where Marc Fiume and his team from DNAstack, a Toronto-based cloud genomics company, have their role to play. Started in 2014, the company began work with some exciting researchers from around Canada whose hot topics included autism and cancer research. But constantly they were told that the researchers just didn’t have enough samples to make sense of all the data they were collecting and that they really needed a platform that would connect them with other researchers globally who found themselves in the same position. Inspired by the concept of Facebook, they decided to build their own platform where genetic research could transpire among researchers worldwide.  He refers to the lack of data access as “potentially keeping life-saving information in a basement server room” and is one of his biggest frustrations when it comes to genomic research. Unveiling the sequence of a genome is challenging, time-consuming and expensive. Perhaps that is the reason why such a platform can no longer be just a notion, but become a mandatory tool so we can further our knowledge unified, instead of trying to connect the dots apart.  Genome sequencing is a lot like “decoding” of a foreign script or ciphering out a code of each individual’s personal genome. It is a long string of letters that forms a sort of molecular blueprint that is unique for each of us. These “strings” of letters are about six billion long, and currently, researchers are only grasping about a very small per cent of what those letters represent. This is why the need for sharing information should be a necessity.  In an attempt to break this societal self-inflicted mold, Marc worked with Dr. Stephen Scherer from The Centre of Applied Genomics on the “Personal Genome Project Canada” to facilitate the publication of health and genome records online for free. The intention being that whether you are sick or healthy, it is incredibly useful personally and for the research community to have your genome sequenced. Perhaps you have a predisposition to a potentially harmful genetic disease that you were not aware of before and could catch it before it starts, or if you are a carrier, or if you simply want to learn more about your ancestry. All of this is possible with genome sequencing. While some may not be ready to have theirs published online, it could still be made available to you in the privacy of your own home.  Marc and Ryan Cook, the other co-founder of DNAstack, have both tried to decrease the unease attached to publicly airing one’s genome sequence by publishing their own. “It’s about empowering and making key decisions about their healthcare in a way that’s not scary and also to break down barriers about data sharing,” comments Marc.  There are now 56 genome researchers that are bearing it all for the world to see, and encouragingly are following up on some of the data that they have found.  DNAstack recently launched their Canadian Genomics Cloud platform that is designed to better connect data, researchers and systems across the country to accelerate genomic discoveries and the implementation of precision medicine. It was invented by Canadian leaders with decades of experience in genomics, sequencing, cloud computing, software, security, and policy to democratize access to best-in-class infrastructure while respecting the unique national and provincial requirements for data privacy and security. Their aim is to service the needs of Canadian genome scientists from research institutions, clinical laboratories, pharmaceutical companies, hospitals, and industry.  The hope is to demonstrate that Canada now does have the capacity to do a precision medicine initiative at scale. Canada is really ready for this.” – says Marc.   +++++  For most of us, the start of a new year is a natural time to reflect on our progress as individuals. We take stock of the lives we’ve lived, the advances we’ve made, the impact we’ve had on those around us and the steps we need to take in the year ahead to achieve our goals.   For the Pharmaceutical and Biotechnology industry, the start of the new year is much the same. Standing at the doorstep of 2018, many of us who have spent our lives trying to advance healthcare around the globe believe that we are at a point in our careers, where science is progressing at a rapid rate.  In fact, some of us would venture that science is progressing at a rate that is outpacing our ability – as healthcare providers, as governments, as payers and as hospital institutions – to integrate these cutting-edge advances into clinical practice. While this reality poses significant challenges, it’s exciting to be on the threshold of so many unprecedented discoveries and novel treatment approaches for some of the world’s most devastating diseases.  The field of biotechnology is rich with discoveries that will have a dramatic impact on Canadians in 2018 and beyond. However, there are three key developments in the area of oncology in which we can expect to see some of the most transformative and immediate changes. These include:  the expanded role of diagnostics to optimize treatment choice;  the adoption of histology-agnostic treatment approaches; and  the next phase of true precision medicine     Expanded Role of Diagnostics  In recent years, the use of diagnostic tests within the Canadian cancer care setting has become an increasingly important practice, particularly for guiding treatment decisions and optimizing the patient’s chances for positive outcomes. In fact, it’s estimated that nearly 70 per cent of all treatment decisions today involve a pathology and/or laboratory investigation.  While the role of predictive biomarker testing has already been well established for some time in certain tumour types (such as HER2 in breast cancer or EGFR and ALK in lung cancer) we are witnessing the emergence of two trends that could further enhance patients’ care and their experience with our healthcare system. These include the ability to simultaneously look beyond a single biomarker through genomic profiling, and the viability of liquid/blood-based biomarker testing.  In 2018 we can expect to see a continued shift among healthcare providers to rely more on comprehensive genomic profiling to map each patient’s unique genomic profile to identify alterations across hundreds of genes known to be relevant in the development and progression of cancer. This broad approach optimizes the use of the available tumour tissue and provides physicians with the most comprehensive information to help guide their treatment selection. There is particular value in this approach for patients who have exhausted all standard treatment options or for those with rare forms of cancer with limited known effective treatment options.  Canadian institutions, like the British Columbia Cancer Agency, University Health Network in Toronto and The Jewish General Hospital in Montreal among many others, have already begun to demonstrate international leadership in this area with their in-house testing platforms and world-class genomic research programs.  We are also seeing the emergence of third-party molecular information providers, such as Foundation Medicine Inc., an organization that has partnered with Roche to offer genomic tests to provide physicians with information about a tumour’s unique genomic profile based on an interrogation of over 300 genes. These external services provide options for institutions that may not have the internal capabilities to offer such testing services and for patients who are looking for more comprehensive diagnostic information. All of these efforts are striving to rapidly expand treatment options by matching patients with approved targeted therapies, immunotherapies, and clinical trials based on their tumour’s molecular profile.  The second emerging trend in the space of predictive biomarkers is blood-based testing, which offers physicians a less-invasive testing mechanism for cases, in which there is insufficient tissue available for analysis. This may also prove to be a better option when a traditional tissue biopsy is not feasible due to tumour location, when a patient is in poor health, or when a physician and/or patient simply prefer a non-surgical option. In addition to supporting initial treatment choice, blood-based testing may also offer physicians the potential for continued monitoring in the future, resulting in earlier detection of disease progression and an assessment of resistance mutations to inform subsequent lines of therapy.     A Change in Mindset  Further to the evolution of diagnostic technologies, the increasing prevalence of targeted medicines is fundamentally challenging the way cancer research is conducted.  We are no longer seeing only large randomized Phase III studies measuring overall survival for drug development, but more novel trial designs, including basket and umbrella studies, as well as smaller Phase II designs to measure the safety and efficacy of a drug.  These new study approaches are aimed to accelerate scientific advancement and are addressing the challenges that exist when the prevalence of a particular molecular alteration is so limited that traditional trials seeking a large bolus of patients simply aren’t feasible.  In a basket trial, the impact of a single treatment across a spectrum of tumour types harbouring a particular alteration can be investigated. In contrast, umbrella trials inverse the approach, where multiple treatments are studied in patients with a common tumour type but who are stratified by molecular subtype.  Close to home, the Canadian Profiling and Targeted Agent Utilization (CAPTUR) trial sponsored by the Canadian Clinical Trials Group in partnership with several pharmaceutical companies and academic institutions across the country is a combined basket/umbrella study enrolling patients of all cancer types who are stratified into different arms of the study to receive treatments based on the genomic profile of their tumours.  Studies like CAPTUR will fundamentally shift how physicians view cancer, forcing them to look less at the type of cancer (e.g., breast, lung, colorectal) and focus on the molecular structure of the tumour.  This histology-agnostic approach is one that is also gaining traction with regulatory authorities around the globe. In fact, the U.S. Food and Drug Administration (FDA) recently approved a PD-1 inhibitor to treat patients with any cancer type, provided their tumours were unresectable or metastatic and classified as microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR).  This approval represented a significant departure from the traditional evidence requirements expected from a regulatory body and opens the door for further discussions and opportunities in other countries.  The final development, which seems like a natural extension of our evolving mindset around the use of diagnostics and targeted medicines in oncology is our view regarding how medicines can be engineered to offer truly individualized treatments to patients.  Though personalized medicines and immunotherapies are no longer considered ‘new’ in the rapidly evolving clinical landscape, the emergence of two types of truly bespoke cancer therapies marry these concepts to create what many consider a bold step in our quest to cure cancer.  Recently, two chimeric antigen receptor (CAR) T-cell therapies were approved in the United States, ushering in the next wave of personalized cancer care. These therapies involve the genetic engineering and reinfusion of a patient’s own T-cells to fight their unique cancers.  While approved in specific hematologic cancers today, researchers are also exploring these therapies in many solid tumours and the hope remains that they will offer a whole new way to think of treatment in cancer.  Still in its infancy, the second area of significant research is personalized cancer vaccines developed and manufactured for an individual patient based on the molecular profile of their tumours. Where off-the-shelf cancer vaccines have failed in the past, there is hope that these custom, uniquely tailored vaccines, in combination with checkpoint inhibitor therapies will succeed in transforming cancer care.  Close  In closing, while it’s easy to become discouraged by the often necessary hurdles required to integrate transformative products into current clinical practice, there has never been a more exciting time for those of who have built a career in the biotechnology industry; and there has never been a more exciting time for those of who have waited for a cure to cancer – a disease that has ravaged many of our families and has taken many of our friends and loved ones.  The reality is that science will continue to outpace clinical practice. But the promise of these discoveries can be realized if we – as stakeholders within the healthcare system – are willing and open-minded to collaborate on solutions, especially as we look at the impact personalized medicines can have in therapeutic areas beyond oncology, offering meaningful solutions to an infinitely greater number of patients, enabling them to live longer, healthier lives.  +++++  The fight against cancer innovation trust announces four new recipients of funding through its prospects oncology investment competition. Those recipients are Dalriada Therapeutics Inc., 16-Bit Inc., a cancer biomarker study at the Ontario Institute for Cancer Research (OICR), and a virus-based therapeutic under development at the Ottawa Hospital and the University of Ottawa.  FACIT’s investments are imperative in bridging the capital gap often experienced by early-stage Ontario companies, helping corporations establish jobs and build roots in the province. The wide-ranging scope of the innovations, which span therapeutics, machine learning and biomarker development, reflect the rich talent pool within the Ontario oncology research community.  Dalriada is a Canadian start-up founded with a mission to develop small molecule-based therapeutic technologies to battle diseases for which current treatment strategies are suboptimal or non-existent. With broad expertise in drug discovery, their efforts are currently centred on the preclinical development of a novel class (DT1) of small molecule inhibitors in cancers of the blood and brain as well as the development of a natural product for topical treatment of psoriasis and other inflammatory skin disorders.  16-Bit, a start-up founded by two medical doctors from the University of Toronto’s Diagnostic Radiology Program, is developing a machine learning algorithm to automate triaging of screening mammograms for breast cancer detection. Their focus is to utilize modern developments in machine intelligence to improve the accuracy, reliability, and speed of medical image interpretation while decreasing cost and barriers to healthcare.  Diagnostics Development Program at OICR leader Dr. John Bartlett has developed a diagnostic gene test to predict which breast cancer patients can benefit from anthracycline chemotherapy and which patients can avoid the associated toxicity because the drug may not be effective against their cancer.  The Ottawa Hospital and the University of Ottawa have developed a tumour-destroying virus based on the Vaccinia virus which adds a micro-RNA payload to enhance cell killing against pancreatic cancer. This targeted therapy is expected to be more precise and less toxic than conventional therapies for this difficult-to-treat tumour.  The Prospects Oncology Fund delivers on FACIT and OICR’s shared vision of advancing breakthrough innovations to the benefit of patients and Ontario’s knowledge economy.  Translating early-stage innovations and positioning them to raise additional funding supports Ontario’s competitive position as a destination for biotechnology.  Congratulations to all the strong applicants and in particular these outstanding awardees in their quest to make a difference for patients living with cancer.  +++++  Well, that wraps up another episode of Biotechnology Focus radio. I hope you enjoyed it. If you have a story idea or would like to be on the show, please email me at press@promotivemedia.ca. To see the articles in full check out the website biotechnologyfocus.ca and laboratoryfocus.ca so you don’t miss a beat! Have a momentous week. From my desk to yours – this is Michelle Currie.      

Rosemarie Truman, CEO of the Center for Advancing Innovation, says a better system of governance for federally funded inventions could lead to many more good ones becoming commercialized.  

Rosemarie Truman, CEO of the Center for Advancing Innovation, says a better system of governance for federally funded inventions could lead to many more good ones becoming commercialized.  

An initiative with programs in over 100 cities around the world is seeing success in the chapter covering the DMV area. "The Founder Institute is a program based out of Silicon Valley, with a mission to bring Silicon Valley to the rest of the world," said Rosemarie Truman, founder and CEO for the Center of Advancing Innovation, as well as the director of the Founder Institute, a program working to help startups grow through mentorship.

Connecting brands to the innovation economy... Michael Reidbord, Founder of the Fashion Tech Consortium (a convergence of designers, brands & global retailers with emerging technologies — advanced materials, and modernized supply chains — creating an ecosystem of partnerships that will lead to the next Industrial Revolution) and a Professor at FIT (profile), joins Marc Raco, Pavan Bahl and Rob Sanchez. Powered by Sennheiser. Upgrading the supply chain, reducing the sampling process, and globalism Reidbord discusses his trade as a clothing manufacturer, and helping stimulate the process of bringing new innovation into the marketplace, starting from design to store floor, and offline. How supply chain hasn’t been upgraded in many years, new ways to warehouse and deliver product, and the enormous opportunity at hand and accelerating the supply chain. Bringing down sampling process time, 3D-body scanning, getting engineers and creative designers together early, and when the outcomes are impressive. On-demand, bringing jobs back to the US, the impact of globalism, when students should be learning skills, and skilled trade vs. university track. And the need to have global skills to compete. Startups vs. legacy, combining efforts to solve problems, and ideas vs. teams Why the genesis of the Fashion Tech Consortium, the experience Reidboard brings by being on his seventh startup, how startups are different than legacy companies and have challenges others don’t understand, engineers are not always best business people, giving support and help to create a platform for them. How technologies are often a baseline for other companies. Looking for really smart, really amazing startups, and being able to help them combine efforts to solve bigger problems. Startups that are getting it done because they are going for it, the importance of a good idea vs. a great team dynamic, and seeing ideas that can’t scale. 20 companies, a big network, and back pocket machines The goal to have 20 companies/quarter, drilling down deep into them as finalists, and the value of pilots. Wanting larger corporations to look at the 20 companies and see the high value and opportunity. Dynamics of older vs. younger entrepreneurs. How the consortium has more than 2,000 companies in its portfolio as a network. Consumer experience in the mix, protecting personal data, standardized cultural curs, and consideration of outliers and nonstandard. Off the Grid Questions cover child labor, bowls of spices, back pocket machines for jeans for five simultaneous sewings, how Pittsburgh has changed, and sustainability.

In our fourth episode, JD White, PhD, talks with Ken Ryalls, PhD, about shifting the paradigm for teaching and learning. Most current approaches, for instance, emphasize using course evaluations to evaluate a faculty member instead of focusing on professional development to improve instruction methods. Ken advocates a holistic system that neither ignores nor overemphasizes student feedback, and rewards classroom engagement, improved teaching, healthy risk-taking, and a pursuit of innovation. Ken Ryalls is President of IDEA, a nonprofit organization dedicated to the improvement of learning in higher education through research, assessment, and professional development.

A conference on the Modi administration's efforts to improve public healthcare in India, and opportunities for private sector coordination.Speakers included Ambassador Taranjit Singh Sandhu, Ambassador Husain Haqqani, Amit Kapoor, Ranjana Smetacek, Kevin Walker, Amiee Aloi, Jeffrey Hamilton, and Jeremiah Norris.

A conference on the Modi administration's efforts to improve public healthcare in India, and opportunities for private sector coordination.Speakers included Ambassador Taranjit Singh Sandhu, Ambassador Husain Haqqani, Amit Kapoor, Ranjana Smetacek, Kevin Walker, Amiee Aloi, Jeffrey Hamilton, and Jeremiah Norris.

Interview about Business Innovation with Patrick J. Stroh, CMA - President of Mercury Business Advisors and author of ‘Advancing Innovation: Galvanizing, Enabling & Measuring for Innovation Value!’ Read the article in Big Blend Radio & TV Magazine> http://www.bigblendnetwork.com/advancing-innovation.html

This video of the panel discussion on America’s Innovation Crisis is the first public release of live, unedited conference proceedings in the three-year history of the IT Security Entrepreneurs Forum (ITSEF). ITSEF III was held at Stanford University on March 18, 2009. Since 2007, ITSEF has focused on advancing innovation in security technologies [...] Related posts:Challenges Created by America’s Transition to an Innovation Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...The Immigration Debate: H-1B Visas and Highly Skilled Technology Entrepreneurs Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation speaks on a...Global Competition and the Critical Role of Venture Capital in America’s Growth Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...

Dr. Curtis Carlson, President and CEO of SRI International, speaking on the panel with Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC and Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation, at the IT Security Entrepreneur’s Forum held at Stanford University on March 18, 2009. Since 2007, ITSEF has focused on advancing innovation in security technologies [...] Related posts:Challenges Created by America’s Transition to an Innovation Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...Exposing the Links Between America’s Innovation Crisis, Cybersecurity, and National Security (ITSEF III full panel presentation) This video of the panel discussion on America’s Innovation Crisis...The Increasing Role of Universities and Research Institutes as Centers of Excellence For Innovation Today Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC speaking on...

Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC speaking on a panel the third annual IT Security Entrepreneurs Forum (ITSEF) held at Stanford University on March 18, 2009 with Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation, and Dr. Curtis Carlson, President and CEO of SRI International. Pascal Levensohn, Founder and Managing Partner of Levensohn [...] Related posts:Global Competition and the Critical Role of Venture Capital in America’s Growth Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...Exposing the Links Between America’s Innovation Crisis, Cybersecurity, and National Security (ITSEF III full panel presentation) This video of the panel discussion on America’s Innovation Crisis...Challenges Created by America’s Transition to an Innovation Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...

Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation speaks on a panel with Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC, Dr. Curtis Carlson, President and CEO of SRI International, and moderator Pascal Levensohn, Founder and Managing Partner of Levensohn Venture Partners. The panel is at the third annual IT Security Entrepreneurs Forum (ITSEF) held at [...] Related posts:Exposing the Links Between America’s Innovation Crisis, Cybersecurity, and National Security (ITSEF III full panel presentation) This video of the panel discussion on America’s Innovation Crisis...Global Competition and the Critical Role of Venture Capital in America’s Growth Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...Unintended Consequences of Regulation Put Fragile VC and Innovation Ecosystems at Grave Risk Dr. Curtis Carlson, President and CEO of SRI International, speaking...

Dr. Curtis Carlson, President and CEO of SRI International, speaking on a panel with Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC and Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation, at the third annual IT Security Entrepreneur’s Forum (ITSEF) held at Stanford University on March 18, 2009. Since 2007, ITSEF has focused on advancing innovation in [...] Related posts:Exposing the Links Between America’s Innovation Crisis, Cybersecurity, and National Security (ITSEF III full panel presentation) This video of the panel discussion on America’s Innovation Crisis...Challenges Created by America’s Transition to an Innovation Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...The Increasing Role of Universities and Research Institutes as Centers of Excellence For Innovation Today Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC speaking on...

Dr. Curtis Carlson, President and CEO of SRI International, speaking on a panel with Dr. Gururaj “Desh” Deshpande, Chairman Sparta Group, LLC, and Lesa Mitchell, VP Advancing Innovation, Kauffman Foundation, at the third annual IT Security Entrepreneurs Forum (ITSEF) held at Stanford University on March 18, 2009. Since 2007, ITSEF has focused on advancing [...] Related posts:Challenges Created by America’s Transition to an Innovation Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...Exposing the Links Between America’s Innovation Crisis, Cybersecurity, and National Security (ITSEF III full panel presentation) This video of the panel discussion on America’s Innovation Crisis...Global Competition and the Critical Role of Venture Capital in America’s Growth Economy Dr. Curtis Carlson, President and CEO of SRI International, speaking...

Advancing Innovation in Healthcare and Public Health Stephen Shortell, Dean, UC Berkeley School of Public Health Moderator Edward O’Neil, Director, Center for the Health Professions, UCSF Innovations in Healthcare Models Mary Pittman, President and CEO, The Public Health Institute Innovations in Public Health Models Carmela Castellano-Garcia, President, California Primary Care Association Innovations in Community Health Clinic Models Robert Pearl, CEO, The Permanente Medical Group Innovations in Physician Practice Leading Change and Innovation is an event for emerging to senior-level leaders in public health and healthcare. The conference provides opportunities for participants to:     * Learn from best-in-class leaders, practitioners, innovators and thinkers     * Gain strategies and skills to catalyze change and innovation in their organizations     * Be exposed to emerging trends and practices in leadership     * Network with engaged community of health leaders     * Gain new ideas to explore and implement in their own organizations More information about the Center for Health Leadership

Advancing Innovation in Healthcare and Public Health Stephen Shortell, Dean, UC Berkeley School of Public Health Moderator Edward O’Neil, Director, Center for the Health Professions, UCSF Innovations in Healthcare Models Mary Pittman, President and CEO, The Public Health Institute Innovations in Public Health Models Carmela Castellano-Garcia, President, California Primary Care Association Innovations in Community Health Clinic Models Robert Pearl, CEO, The Permanente Medical Group Innovations in Physician Practice Leading Change and Innovation is an event for emerging to senior-level leaders in public health and healthcare. The conference provides opportunities for participants to:     * Learn from best-in-class leaders, practitioners, innovators and thinkers     * Gain strategies and skills to catalyze change and innovation in their organizations     * Be exposed to emerging trends and practices in leadership     * Network with engaged community of health leaders     * Gain new ideas to explore and implement in their own organizations More information about the Center for Health Leadership